Clinical study on the safety and efficacy of human embryonic stem cell-derived retinal pigment epithelial cells transplantation for the treatment of macular hole of high myopia

General Information

Clinical trials phase Other
Start date (estimated) 2022-01-15
End date (estimated) 2022-12-31
Clinical feature
Label macular holes
Link http://purl.obolibrary.org/obo/DOID_7633

Administrative Information

ICTRP weblink https://trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR2200055625
Source weblink https://www.chictr.org.cn/showproj.html?proj=149382
Public contact
Email 659919036@qq.com
Public email 659919036@qq.com
First name Fang
Last name Wang
Phone +86 18375722981
City Chongqing
Country
China
Sponsors Southwest Hospital, China

Cells

Which differentiated cell type is used
Label retinal pigment epithelial cell
Link http://purl.obolibrary.org/obo/CL_0002586
Description An epithelial cell of the retinal pigmented epithelium.

Recruitment

Recruitment Status Recruiting
Estimated number of participants 12